Pretreatment with resveratrol prevents neuronal injury and cognitive deficits induced by perinatal hypoxia-ischemia in rats

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Arteaga, Olatz ^a   Revuelta, Miren ^a   Urigüen, Leyre ^a,b   Álvarez, Antonia ^a   Montalvo, Haizea ^a   Hilario, Enrique ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE; RESVERATROL; MBP PROTEIN, RAT; MYELIN BASIC PROTEIN; NEUROPROTECTIVE AGENT; STILBENE DERIVATIVE;

ADULTHOOD; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN INJURY; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG MECHANISM; HYPOXIC ISCHEMIC ENCEPHALOPATHY; MACROGLIA; MITOCHONDRIAL MEMBRANE POTENTIAL; MYELINATION; NEUROPROTECTION; NEWBORN; NONHUMAN; PERINATAL PERIOD; RAT; TREATMENT OUTCOME; ANIMAL; ASTROCYTE; BRAIN; BRAIN INJURIES; COGNITION DISORDERS; DISEASE MODEL; DRUG EFFECTS; FEMALE; HYPOXIA-ISCHEMIA, BRAIN; MALE; METABOLISM; MITOCHONDRION; PATHOLOGY; PSYCHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BEHAVIOR, ANIMAL; BRAIN; BRAIN INJURIES; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; FEMALE; HYPOXIA-ISCHEMIA, BRAIN; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; MYELIN BASIC PROTEIN; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; STILBENES;

EID: 84952673796     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142424     Document Type: Article

References (82)

1. du Plessis AJ, Volpe JJ. Perinatal brain injury in the preterm and term newborn. Curr Opin Neurol 2002 Apr; 15(2):151-157. PMID: 11923628
2. Azra Haider B, Bhutta ZA. Birth asphyxia in developing countries: current status and public health implications. Curr Probl Pediatr Adolesc Health Care 2006 May-Jun; 36(5):178-188. PMID: 16631096
3. Jiang H, Lei JJ, Zhang YH. Protective effect of topiramate on hypoxic-ischemic brain injury in neonatal rat. Asian Pac J Trop Med 2014 Jun; 7(6):496-500. doi:10.1016/S1995-7645 (14) 60082-1 PMID: 25066402
4. Volpe JJ. Perinatal brain injury: from pathogenesis to neuroprotection. Ment Retard Dev Disabil Res Rev 2001;7(1):56-64. PMID: 11241883
5. Low JA. Determining the contribution of asphyxia to brain damage in the neonate. J Obstet Gynaecol Res 2004 Aug; 30(4):276-286. PMID: 15238103
6. Vannucci SJ, Hagberg H. Hypoxia-ischemia in the immature brain. J Exp Biol 2004 Aug; 207(Pt 18):3149-3154. PMID: 15299036
7. Aridas JD, Yawno T, Sutherland AE, Nitsos I, Ditchfield M, Wong FY, et al. Detecting brain injury in neonatal hypoxic ischemic encephalopathy: Closing the gap between experimental and clinical research. Exp Neurol 2014 Jul. 28; 261 C: 281-290.
8. Ferriero DM. Neonatal brain injury. N Engl J Med 2004 Nov. 4;351(19):1985-1995. PMID: 15525724
9. Juul SE, Ferriero DM. Pharmacologic neuroprotective strategies in neonatal brain injury. Clin Perinatol 2014 Mar; 41(1):119-131. doi:10.1016/j.clp. 2013.09.004 PMID: 24524450
10. Lai MC, Yang SN. Perinatal hypoxic-ischemic encephalopathy. J Biomed Biotechnol 2011;2011:609813. doi:10.1155/2011/609813 PMID: 21197402
11. Levene ML, Kornberg J, Williams TH. The incidence and severity of post-asphyxial encephalopathy in full-term infants. Early Hum Dev 1985 May; 11(1):21-26. PMID: 4006822
12. Goñi de Cerio F, Lara-Celador I, Álvarez A, Hilario E. Neuroprotective Therapies after perinatal hypoxic-ischemic brain injury, Brain Sci 2013, 3:191-214. doi:10.3390/brainsci3010191 PMID: 24961314
13. Northington FJ, Ferriero DM, Graham EM, Traystman RJ, Martin LJ. Early Neurodegeneration after Hypoxia-Ischemia in Neonatal Rat Is Necrosis while Delayed Neuronal Death Is Apoptosis. Neurobiol Dis 2001 Apr; 8(2):207-219. PMID: 11300718
14. Hilario E, Rey-Santano MC, Goni-de-Cerio F, Alvarez FJ, Gastiasoro E, Mielgo VE, et al. Cerebral blood flow and morphological changes after hypoxic-ischaemic injury in preterm lambs. Acta Paediatr 2005 Jul; 94(7):903-911. PMID: 16188813
15. Chen Y, Swanson RA. Astrocytes and brain injury. J Cereb Blood Flow Metab 2003 Feb; 23(2):137-149. PMID:12571445
16. Alvarez-Diaz A, Hilario E, de Cerio FG, Valls-i-Soler A, Alvarez-Diaz FJ. Hypoxic-ischemic injury in the immature brain-key vascular and cellular players. Neonatology 2007;92(4):227-235. PMID: 17556841
17. Rothstein RP, Levison SW. Gray matter oligodendrocyte progenitors and neurons die caspase-3 mediated deaths subsequent to mild perinatal hypoxic/ischemic insults. Dev Neurosci 2005 Mar-Aug; 27(2-4):149-159. PMID: 16046849
18. Butt AM, Fern RF, Matute C. Neurotransmitter signaling in white matter. Glia 2014 Nov; 62(11):1762-1779. doi:10.1002/glia.22674 PMID: 24753049
19. Northington FJ, Chavez-Valdez R, Martin LJ. Neuronal cell death in neonatal hypoxia-ischemia. Ann Neurol 2011 May; 69(5):743-758. doi:10.1002/ana.22419 PMID: 21520238
20. Li X, Zhang J, Chai S, Wang X. Progesterone alleviates hypoxic-ischemic brain injury via the Akt/GSK-3beta signaling pathway. Exp Ther Med 2014 Oct; 8(4):1241-1246. PMID: 25187832
21. Warner DS, Sheng H, Batinic-Haberle I. Oxidants, antioxidants and the ischemic brain. J Exp Biol 2004 Aug; 207(Pt 18):3221-3231. PMID: 15299043
22. Ferriero DM. Oxidant mechanisms in neonatal hypoxia-ischemia. Dev Neurosci. 2001;23(3):198-202. PMID: 11598320
23. Revuelta M, Arteaga O, Montalvo H, Alvarez A, Hilario E, Martinez-Ibargüen A. Antioxidant treatments recover the alteration of auditory evoked potentials and reduce morphological damage in the inferior colliculus after perinatal asphyxia in rat. Brain Pathology 2015 May.
24. Baba L, McGrath JM. Oxygen free radicals: effects in the newborn period. Adv Neonatal Care 2008 Oct; 8(5):256-264. doi:10.1097/01. ANC.0000338015.25911.8a PMID: 18827514
25. Smoliga JM, Baur JA, Hausenblas HA. Resveratrol and health-a comprehensive review of human clinical trials, Mol Nutr Food Res 2011, 55(8):1129-41 doi:10.1002/mnfr.201100143 PMID: 21688389
26. Pallas M, Porquet D, Vicente A, Sanfeliu C. Resveratrol: new avenues for a natural compound in neuroprotection. Curr Pharm Des 2013;19(38):6726-6731. PMID: 23530512
27. Liu BL, Zhang X, Zhang W, Zhen HN. New enlightenment of French Paradox: resveratrol's potential for cancer chemoprevention and anti-cancer therapy. Cancer Biol Ther 2007 Dec; 6(12):1833-1836. PMID: 18087218
28. Catalgol B, Batirel S, Taga Y, Ozer NK. Resveratrol: French paradox revisited. Front Pharmacol 2012 Jul. 17;3:141. doi:10.3389/fphar.2012.00141 PMID: 22822401
29. Vingtdeux V, Dreses-Werringloer U, Zhao H, Davies P, Marambaud P. Therapeutic potential of resveratrol in Alzheimer's disease. BMC Neurosci 2008 Dec. 3; 9 Suppl 2:S6-2202-9-S2-S6.
30. Albani D, Polito L, Signorini A, Forloni G. Neuroprotective properties of resveratrol in different neurodegenerative disorders. Biofactors 2010 Sep-Oct; 36(5):370-376. doi:10.1002/biof.118 PMID: 20848560
31. Ferretta A, Gaballo A, Tanzarella P, Piccoli C, Capitanio N, Nico B, et al. Effect of resveratrol on mitochondrial function: implications in parkin-associated familiar Parkinson's disease. Biochim Biophys Acta 2014 Jul; 1842(7):902-915. doi:10.1016/j.bbadis.2014.02.010 PMID: 24582596
32. Rege SD, Geetha T, Griffin GD, Broderick TL, Babu JR. Neuroprotective effects of resveratrol in Alzheimer disease pathology. Front Aging Neurosci 2014 Sep. 11;6:218. doi:10.3389/fnagi.2014.00218 PMID: 25309423
33. Mokni M, Hamlaoui S, Karkouch I, Amri M, Marzouki L, Limam F, et al. Resveratrol Provides Cardioprotection after Ischemia/reperfusion Injury via Modulation of Antioxidant Enzyme Activities. Iran J Pharm Res 2013 Fall; 12(4):867-875. PMID: 24523766
34. Liu C, Shi Z, Fan L, Zhang C, Wang K, Wang B. Resveratrol improves neuron protection and functional recovery in rat model of spinal cord injury. Brain Res 2011 Feb. 16;1374:100-109. doi:10.1016/j. brainres.2010.11.061 PMID: 21111721
35. Wang HD, Shi YM, Li L, Guo JD, Zhang YP, Hou SX. Treatment with resveratrol attenuates sublesional bone loss in spinal cord-injured rats. Br J Pharmacol 2013 Oct; 170(4):796-806. doi:10.1111/bph. 12301 PMID: 23848300
36. Kesherwani V, Atif F, Yousuf S, Agrawal SK. Resveratrol protects spinal cord dorsal column from hypoxic injury by activating Nrf-2. Neuroscience 2013 Jun. 25;241:80-88. doi:10.1016/j.neuroscience. 2013.03.015 PMID: 23523995
37. Wang R, Liu YY, Liu XY, Jia SW, Zhao J, Cui D, et al. Resveratrol protects neurons and the myocardium by reducing oxidative stress and ameliorating mitochondria damage in a cerebral ischemia rat model. Cell Physiol Biochem 2014;34(3):854-864. doi:10.1159/000366304 PMID: 25199673
38. Volpe JJ. Brain injury in the premature infant: overview of clinical aspects, neuropathology, and pathogenesis. Semin. Pediatr. Neurol 1998;5:135-51. PMID: 9777673
39. Hagberg H, Bona E, Gilland E, Puka-Sundvall M. Hypoxia-ischaemia model in the 7-day-old rat: possibilities and shortcomings. Acta. Paediatr. Suppl 1997;422:85-8. PMID: 9298801
40. Rice JE 3rd, Vannucci RC, Brierley JB. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 1981 Feb; 9(2):131-141. PMID: 7235629
41. West T, Atzeva M, Holtzman DM. Pomegranate polyphenols and resveratrol protect the neonatal brain against hypoxic-ischemic injury. Dev Neurosci 2007;29(4-5):363-372. PMID: 17762204
42. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd edition. Edited by Academic Press, 1986.
43. Hedtjarn M, Leverin AL, Eriksson K, Blomgren K, Mallard C, Hagberg H. Interleukin-18 involvement in hypoxic-ischemic brain injury. J Neurosci 2002 Jul. 15;22(14):5910-5919. PMID: 12122053
44. Karalis F, Soubasi V, Georgiou T, Nakas CT, Simeonidou C, Guiba-Tziampiri O, et al. Resveratrol ameliorates hypoxia/ischemia-induced behavioral deficits and brain injury in the neonatal rat brain. Brain Res 2011 Nov. 24;1425:98-110. doi:10.1016/j.brainres.2011.09.044 PMID: 22018692
45. Sizonenko SV, Camm EJ, Dayer A, Kiss JZ. Glial responses to neonatal hypoxic-ischemic injury in the rat cerebral cortex. Int J Dev Neurosci 2008 Feb; 26(1):37-45. PMID: 17942266
46. Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB, Sofroniew MV. Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 2004 Mar. 3;24(9):2143-2155. PMID: 14999065
47. Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol 2010 Jan; 119(1):7-35. doi:10.1007/s00401-009-0619-8 PMID: 20012068
48. Sanches EF, Arteni NS, Nicola F, Boisserand L, Willborn S, Netto CA. Early hypoxia-ischemia causes hemisphere and sex-dependent cognitive impairment and histological damage. Neuroscience 2013 May 1;237:208-215. doi:10.1016/j.neuroscience.2013.01.066 PMID: 23395861
49. Alonso-Alconada D, Alvarez A, Lacalle J, Hilario E. Histological study of the protective effect of melatonin on neural cells after neonatal hypoxia-ischemia. Histol Histopathol 2012 Jun; 27(6):771-783. PMID: 22473697
50. Morin C, Zini R, Albengres E, Bertelli AA, Bertelli A, Tillement JP. Evidence for resveratrol-induced preservation of brain mitochondria functions after hypoxia-reoxygenation. Drugs Exp Clin Res. 2003;29(5-6):227-33. PMID: 15134379
51. Girbovan C, Kent P, Merali Z, Plamondon H. Dose-related effects of chronic resveratrol administration on neurogenesis, angiogenesis, and corticosterone secretion are associated with improved spatial memory retention following global cerebral ischemia. Nutr Neurosci. 2015 Apr. 11.
52. Gülçin I. Antioxidant properties of resveratrol: a structure-activity insight. Innovative Food Science and Emerging Technologies 2010, 11:210-218.
53. Bastianetto S, Menard C, Quirion R. Neuroprotective action of resveratrol. Biochim Biophys Acta 2014 Oct. 2.
54. Venturini CD, Merlo S, Souto AA, Fernandes Mda C, Gomez R, Rhoden CR. Resveratrol and red wine function as antioxidants in the nervous system without cellular proliferative effects during experimental diabetes. Oxid Med Cell Longev 2010 Nov-Dec; 3(6):434-441. PMID: 21307644
55. Sinha K, Chaudhary G, Gupta YK. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci 2002 Jun. 28;71(6):655-665. PMID: 12072154
56. Yousuf S, Atif F, Ahmad M, Hoda N, Ishrat T, Khan B, et al. Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia. Brain Res 2009 Jan 23;1250:242-253. doi:10.1016/j.brainres.2008.10.068 PMID: 19027723
57. Hagberg H, Mallard C, Rousset CI, Thornton C. Mitochondria: hub of injury responses in the developing brain. Lancet Neurol 2014;13(2):217-232. doi:10.1016/S1474-4422 (13) 70261-8 PMID: 24457191
58. Thrnton C, Hagberg H. Role of mitochondria in apoptotic and necroptotic cell death in the developing brain. Clin Chim Acta. 2015, in press, doi:10.1016/j.cca.2015.01.026 PMID: 25661091
59. Darzynkiewicz Z, Staiano-Coico L, Melamed MR. Increased mitochondrial uptake of rhodamine 123 during lymphocyte stimulation. Proc Natl Acad Sci USA. 1981 Apr; 78(4):2383-7. PMID: 6941298
60. Zhao J, Bolton EM, Bradley JA, Lever AM. Lentiviral-mediated overexpression of Bcl-xL protects primary endothelial cells from ischemia/reperfusion injury-induced apoptosis. J Heart Lung Transplant 2009;28:936-943. doi:10.1016/j.healun. 2009.05.014 PMID: 19716047
61. Dong W, Gao D, Zhang X. Mitochondria biogenesis induced by resveratrol against brain ischemic stroke. Med Hypotheses. 2007;69(3):700-1. Epub 2007 Mar. 26. PMID: 17368753
62. Meng XJ, Wang F, Li CK. Resveratrol is Neuroprotective and Improves Cognition in Pentylenetetrazole-kindling Model of Epilepsy in Rats. Indian J Pharm Sci 2014 Mar; 76(2):125-131. PMID: 24843185
63. Sahu SS, Madhyastha S, Rao GM. Neuroprotective effect of resveratrol against prenatal stress induced cognitive impairment and possible involvement of Na (+), K (+)-ATPase activity. Pharmacol Biochem Behav 2013 Jan; 103(3):520-525. doi:10.1016/j.pbb.2012.09.012 PMID: 23044472
64. Witte AV, Kerti L, Margulies DS, Floel A. Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults. J Neurosci 2014 Jun. 4;34(23):7862-7870. doi:10.1523/JNEUROSCI.0385-14.2014 PMID: 24899709
65. Wong RH, Coates AM, Buckley JD, Howe PR. Evidence for circulatory benefits of resveratrol in humans. Ann N Y Acad Sci 2013 Jul; 1290:52-58. doi:10.1111/nyas.12155 PMID: 23855465
66. Damodaran T, Hassan Z, Navaratnam V, Muzaimi M, Ng G, Muller CP, et al. Time course of motor and cognitive functions after chronic cerebral ischemia in rats. Behav Brain Res 2014 Sep. 17; 275 C: 252-258.
67. Lubics A, Reglodi D, Tamas A, Kiss P, Szalai M, Szalontay L, et al. Neurological reflexes and early motor behavior in rats subjected to neonatal hypoxic-ischemic injury. Behav Brain Res 2005 Feb. 10;157(1):157-165. PMID: 15617782
68. Balduini W, De Angelis V, Mazzoni E, Cimino M. Long-lasting behavioral alterations following a hypoxic/ischemic brain injury in neonatal rats. Brain Res 2000 Mar. 24;859(2):318-325. PMID: 10719080
69. Sab IM, Ferraz MM, Amaral TA, Resende AC, Ferraz MR, Matsuura C, et al. Prenatal hypoxia, habituation memory and oxidative stress. Pharmacol Biochem Behav 2013 Jun; 107:24-28. doi:10.1016/j. pbb.2013.04.004 PMID: 23584097
70. Xie C, Zhou K, Wang X, Blomgren K, Zhu C. Therapeutic benefits of delayed lithium administration in the neonatal rat after cerebral hypoxia-ischemia. PLoS One 2014 Sep. 11;9(9):e107192. doi:10.1371/journal.pone.0107192 PMID: 25211332
71. Lee B, Sur B, Yeom M, Shim I, Lee H, Hahm DH. Alpha-Asarone, a Major Component of Acorus gramineus, Attenuates Corticosterone-Induced Anxiety-Like Behaviours via Modulating TrkB Signaling Process. Korean J Physiol Pharmacol 2014 Jun; 18(3):191-200. doi:10.4196/kjpp. 2014.18.3.191 PMID: 24976758
72. Pazos MR, Cinquina V, Gomez A, Layunta R, Santos M, Fernandez-Ruiz J, et al. Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function. Neuropharmacology 2012 Oct; 63(5):776-783. doi:10.1016/j.neuropharm.2012.05.034 PMID: 22659086
73. Ikeda T, Mishima K, Yoshikawa T, Iwasaki K, Fujiwara M, Xia YX, Ikenoue T. Selective and long-term learning impairment following neonatal hypoxic-ischemic brain insult in rats. Behav Brain Res 2001;118:17-25. PMID: 11163630
74. Arteni NS, Salgueiro J, Torres I, Achaval M, Netto CA. Neonatal cerebral hypoxia-ischemia causes lateralized memory impairments in the adult rat. Brain Research 2003;973:171-178. PMID: 12738060
75. Arteni NS, Pereira LO, Rodrigues AL, Lavinsky D, Achaval ME, Netto CA. Lateralized and sex-dependent behavioral and morphological effects of unilateral neonatal cerebral hypoxia-ischemia in the rat. Behav Brain Res 2010;1301:100-109.
76. Pereira LO, Arteni NS, Petersen RC, Da Rocha AP, Acheval M, Netto CA. Effects of daily environmental enrichment on memory deficits and brain injury following neonatal hypoxia-ischemia in the rat. Neurobiology of Learning and Memory 2007;87:101-108. PMID: 16931063
77. Huang Z, Liu J, Cheung P-Y, Cheng C. Long-term cognitive impairment and myelination deficiency in a rat model of perinatal hypoxic-ischemic brain injury. Brain Res 2009;1301:100-109. doi:10.1016/j. brainres.2009.09.006 PMID: 19747899
78. Broadbent NJ, Gaskin S, Squire LR, Clark RE. Object recognition memory and the rodent hippocampus. Learn Mem 2009 Dec. 22;17(1):5-11. doi:10.1101/lm.1650110 PMID: 20028732
79. Dere E, Huston JP, De Souza Silva MA. The pharmacology, neuroanatomy and neurogenetics of onetrial object recognition in rodents. Neurosci Biobehav Rev 2007;31(5):673-704. PMID: 17368764
80. Ennaceur A, Delacour J. A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data. Behav Brain Res 1988 Nov. 1;31(1):47-59. PMID: 3228475
81. Morrow BA, Elsworth JD, Roth RH. Prenatal cocaine exposure disrupts non-spatial, short-term memory in adolescent and adult male rats. Behav Brain Res 2002 Feb. 1;129(1-2):217-223. PMID: 11809514
82. Simola N, Bustamante D, Pinna A, Pontis S, Morales P, Morelli M, et al. Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats. Exp Brain Res 2008 Mar; 185(4):595-601. PMID: 17989968